DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Emend (Aprepitant) - Dyspnoea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dyspnoea (18)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Emend (Aprepitant) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Emend side effects in

Reported by a pharmacist from United States on 2012-08-23

Patient:

Reactions: Dyspnoea, Chest Pain

Drug(s) suspected as cause:
Emend
    Dosage: 150 mg, once
    Start date: 2012-05-03

Emend
    Dosage: 150 mg, once
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2012-05-24

Other drugs received by patient: Taxol; Taxol; Cisplatin; Cisplatin



Possible Emend side effects in male

Reported by a physician from France on 2012-07-31

Patient: male

Reactions: Dyspnoea, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alimta
    Dosage: 900 mg, daily
    Indication: Lung Neoplasm Malignant
    Start date: 2012-03-05
    End date: 2012-05-15

Cisplatin
    Dosage: 140 mg, unk
    Start date: 2012-03-05
    End date: 2012-05-15

Dexamethasone
    Dosage: 4 mg, bid
    Administration route: Oral
    Start date: 2012-03-04
    End date: 2012-05-16

Emend
    Dosage: 125 mg, unk
    Administration route: Oral
    Start date: 2012-03-03
    End date: 2012-03-15

Folic Acid
    Dosage: 0.4 mg, daily
    Administration route: Oral
    Start date: 2012-03-01

Lyrica
    Dosage: 100 mg, bid

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-03-05
    End date: 2012-03-15

Ondansetron
    Dosage: 8 mg, unk
    Start date: 2012-03-03
    End date: 2012-03-15

Oxycodone Hydrochloride
    Dosage: 5 mg, prn
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Oxycontin
    Dosage: 90 mg, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Zometa
    Dosage: unk
    Start date: 2012-05-15
    End date: 2012-05-15



Possible Emend side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-31

Patient:

Reactions: Dyspnoea, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alimta
    Dosage: 900 mg, once
    Start date: 2012-03-05
    End date: 2012-03-05

Alimta
    Dosage: 900 mg, once
    Start date: 2012-03-27
    End date: 2012-03-27

Alimta
    Dosage: 900 mg, once
    Start date: 2012-04-17
    End date: 2012-04-17

Alimta
    Dosage: 900 mg, once
    Start date: 2012-05-15
    End date: 2012-05-15

Cisplatin
    Dosage: 140 mg, once
    Start date: 2012-03-05
    End date: 2012-03-05

Cisplatin
    Dosage: 140 mg, once
    Start date: 2012-05-15
    End date: 2012-05-15

Cisplatin
    Dosage: 140 mg, once
    Start date: 2012-03-27
    End date: 2012-03-27

Cisplatin
    Dosage: 140 mg, once
    Start date: 2012-04-17
    End date: 2012-04-17

Dexamethasone
    Dosage: 4 mg, bid
    Administration route: Oral
    Start date: 2012-03-04
    End date: 2012-03-06

Dexamethasone
    Dosage: 4 mg, bid
    Start date: 2012-04-16
    End date: 2012-04-16

Dexamethasone
    Dosage: 4 mg, bid
    Administration route: Oral
    Start date: 2012-05-14
    End date: 2012-05-16

Dexamethasone
    Dosage: 4 mg, bid
    Administration route: Oral
    Start date: 2012-03-26
    End date: 2012-03-28

Emend
    Dosage: 125 mg, once
    Administration route: Oral
    Start date: 2012-05-15
    End date: 2012-05-15

Emend
    Dosage: 125 mg, once
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-03-05

Emend
    Dosage: 125 mg, once
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-03-27

Emend
    Dosage: 125 mg, once
    Administration route: Oral
    Start date: 2012-04-17
    End date: 2012-04-17

Folic Acid
    Dosage: 0.4 mg, qd
    Administration route: Oral
    Start date: 2012-02-27
    End date: 2012-06-04

Lyrica
    Dosage: 100 mg, bid
    Administration route: Oral

Methylprednisolone
    Dosage: 120 mg, once
    Start date: 2012-04-17
    End date: 2012-04-17

Methylprednisolone
    Dosage: 120 mg, once
    Start date: 2012-03-05
    End date: 2012-03-05

Methylprednisolone
    Dosage: 120 mg, once
    Start date: 2012-05-15
    End date: 2012-05-15

Methylprednisolone
    Dosage: 120 mg, once
    Start date: 2012-03-27
    End date: 2012-03-27

Ondansetron
    Dosage: 8 mg, once
    Start date: 2012-05-15
    End date: 2012-05-15

Ondansetron
    Dosage: 8 mg, once
    Start date: 2012-04-17
    End date: 2012-04-17

Ondansetron
    Dosage: 8 mg, once
    Start date: 2012-03-27
    End date: 2012-03-27

Ondansetron
    Dosage: 8 mg, once
    Start date: 2012-03-05
    End date: 2012-03-05

Oxycontin
    Dosage: 90 mg, qd
    Administration route: Oral

Zometa
    Dosage: unk
    Start date: 2012-05-15
    End date: 2012-05-15

Other drugs received by patient: Oxycodone HCL; Cyanocobalamin



Possible Emend side effects in

Reported by a pharmacist from United States on 2012-07-27

Patient:

Reactions: Dyspnoea, Chest Pain

Drug(s) suspected as cause:
Emend
    Dosage: 150 mg, once
    Start date: 2012-05-03

Emend
    Dosage: 150 mg, once
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2012-05-24

Other drugs received by patient: Taxol; Taxol; Cisplatin; Cisplatin



Possible Emend side effects in 63 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient: 63 year old male

Reactions: Dyspnoea, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alimta
    Dosage: 900 mg, cyclic
    Indication: Lung Adenocarcinoma
    Start date: 2012-03-05
    End date: 2012-05-15

Cisplatin
    Dosage: 140 mg, cyclic
    Indication: Lung Adenocarcinoma
    Start date: 2012-03-05
    End date: 2012-05-15

Dexamethasone
    Dosage: 4 mg, 2x/day
    Administration route: Oral
    Start date: 2012-03-04
    End date: 2012-05-16

Emend
    Dosage: 125 mg, cyclic
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-05-15

Folic Acid
    Dosage: 0.4 mg, 1x/day
    Administration route: Oral
    Start date: 2012-03-01

Lyrica
    Dosage: 100 mg, 2x/day
    Administration route: Oral

Methylprednisolone
    Dosage: 120 mg, cyclic
    Start date: 2012-03-05
    End date: 2012-05-15

Ondansetron
    Dosage: 8 mg, cyclic
    Start date: 2012-03-05
    End date: 2012-05-15

Oxycontin
    Dosage: 40 mg in the morning and 50 mg in the evening
    Administration route: Oral

Zometa
    Dosage: unk
    Start date: 2012-05-15
    End date: 2012-05-15

Other drugs received by patient: Vitamin B-12; Oxyconorm



Possible Emend side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-24

Patient: male

Reactions: Dyspnoea, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alimta
    Dosage: 500 mg/m2, unk
    Start date: 2012-05-15

Alimta
    Dosage: 500 mg/m2, unk
    Indication: Lung Adenocarcinoma
    Start date: 2012-03-05

Alimta
    Dosage: 500 mg/m2, unk
    Start date: 2012-03-27

Alimta
    Dosage: 500 mg/m2, unk
    Start date: 2012-04-17

Cisplatin
    Dosage: 75 mg/m2, unk
    Start date: 2012-05-15

Cisplatin
    Dosage: 75 mg/m2, unk
    Start date: 2012-04-17

Cisplatin
    Dosage: 75 mg/m2, unk
    Indication: Lung Adenocarcinoma
    Start date: 2012-03-05

Cisplatin
    Dosage: 75 mg/m2, unk
    Start date: 2012-03-27

Dexamethasone
    Dosage: 4 mg, bid
    Start date: 2012-04-04
    End date: 2012-05-16

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-03-05

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-03-27

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-04-17

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-05-15

Folic Acid
    Dosage: 0.4 mg, daily one week
    Administration route: Oral
    Start date: 2012-03-01

Lyrica
    Dosage: 100 mg, bid
    Administration route: Oral

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-03-05

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-05-15

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-04-17

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-03-27

Ondansetron
    Dosage: 8 mg, daily

Oxycontin
    Dosage: 90 mg, daily

Zometa
    Start date: 2012-05-15

Other drugs received by patient: Oxycodone HCL; Vitamin B-12



Possible Emend side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-24

Patient: male

Reactions: Dyspnoea, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alimta
    Dosage: 500 mg/m2, unk
    Start date: 2012-05-15

Alimta
    Dosage: 500 mg/m2, unk
    Start date: 2012-03-27

Alimta
    Dosage: 500 mg/m2, unk
    Indication: Lung Adenocarcinoma
    Start date: 2012-03-05

Alimta
    Dosage: 500 mg/m2, unk
    Start date: 2012-04-17

Cisplatin
    Dosage: 75 mg/m2, unk
    Start date: 2012-03-27

Cisplatin
    Dosage: 75 mg/m2, unk
    Start date: 2012-04-17

Cisplatin
    Dosage: 75 mg/m2, unk
    Start date: 2012-05-15

Cisplatin
    Dosage: 75 mg/m2, unk
    Indication: Lung Adenocarcinoma
    Start date: 2012-03-05

Dexamethasone
    Dosage: 4 mg, bid
    Start date: 2012-04-04
    End date: 2012-05-16

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-03-27

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-05-15

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-03-05

Emend
    Dosage: 125 mg, daily
    Administration route: Oral
    Start date: 2012-04-17

Folic Acid
    Dosage: 0.4 mg, daily one week
    Administration route: Oral
    Start date: 2012-03-01

Lyrica
    Dosage: 100 mg, bid
    Administration route: Oral

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-03-27

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-04-17

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-03-05

Methylprednisolone
    Dosage: 120 mg, unk
    Start date: 2012-05-15

Ondansetron
    Dosage: 8 mg, daily

Oxycontin
    Dosage: 90 mg, daily

Zometa
    Start date: 2012-05-15

Other drugs received by patient: Oxycodone HCL; Vitamin B-12



Possible Emend side effects in female

Reported by a pharmacist from United States on 2012-06-05

Patient: female, weighing 70.8 kg (155.7 pounds)

Reactions: Dyspnoea, Erythema, Infusion Related Reaction

Drug(s) suspected as cause:
Emend

Other drugs received by patient: Decadron; Aloxi



Possible Emend side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-29

Patient: 60 year old female, weighing 49.4 kg (108.8 pounds)

Reactions: Flushing, Dyspnoea, Hypotension, Feeling Hot

Drug(s) suspected as cause:
Emend

Other drugs received by patient: Zantac; Aloxi; Benadryl; Dexamethasone; Taxol; Cisplatin



Possible Emend side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-16

Patient: 60 year old male, weighing 98.0 kg (215.6 pounds)

Reactions: Blood Pressure Increased, Flushing, Back Pain, Dyspnoea, Flank Pain, Erythema

Drug(s) suspected as cause:
Emend
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2011-07-01

Fosaprepitant Dimeglumine
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2011-07-11
    End date: 2011-07-11

Fosaprepitant Dimeglumine
    Start date: 2011-06-13

Other drugs received by patient: Cisplatin; Fluorouracil; Trastuzumab



Possible Emend side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-01-31

Patient: 40 year old female, weighing 64.0 kg (140.8 pounds)

Reactions: Malaise, Dyspnoea, Nausea, Type I Hypersensitivity

Drug(s) suspected as cause:
Carboplatin
    Indication: Ovarian Cancer
    Start date: 2011-12-30
    End date: 2011-12-30

Clemastine Fumarate
    Start date: 2011-12-30

Dexamethasone Sodium Phosphate
    Indication: Nausea
    Start date: 2011-12-30

Dexamethasone Sodium Phosphate
    Indication: Vomiting
    Start date: 2011-12-30

Emend
    Administration route: Oral
    Indication: Nausea
    Start date: 2011-12-30

Emend
    Administration route: Oral
    Indication: Vomiting
    Start date: 2011-12-30

Ondansetron HCL
    Indication: Nausea
    Start date: 2011-12-30

Ondansetron HCL
    Indication: Vomiting
    Start date: 2011-12-30

Paclitaxel
    Indication: Ovarian Cancer
    Start date: 2011-12-30

Zantac
    Start date: 2011-12-30



Possible Emend side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-01-27

Patient: 40 year old female, weighing 64.0 kg (140.8 pounds)

Reactions: Malaise, Dyspnoea, Nausea, Type III Immune Complex Mediated Reaction

Drug(s) suspected as cause:
Carboplatin
    Indication: Ovarian Cancer
    Start date: 2011-12-30
    End date: 2011-12-30

Clemastine Fumarate
    Start date: 2011-12-30

Dexamethasone Sodium Phosphate
    Indication: Vomiting
    Start date: 2011-12-30

Dexamethasone Sodium Phosphate
    Indication: Nausea
    Start date: 2011-12-30

Emend
    Administration route: Oral
    Indication: Vomiting
    Start date: 2011-12-30

Emend
    Administration route: Oral
    Indication: Nausea
    Start date: 2011-12-30

Ondansetron HCL
    Indication: Vomiting
    Start date: 2011-12-30

Ondansetron HCL
    Indication: Nausea
    Start date: 2011-12-30

Paclitaxel
    Indication: Ovarian Cancer
    Start date: 2011-12-30

Zantac
    Start date: 2011-12-30



Possible Emend side effects in 68 year old male

Reported by a pharmacist from United States on 2011-12-12

Patient: 68 year old male

Reactions: Anxiety, Respiratory Disorder, Chest Discomfort, Dyspnoea, Nausea, Chills, Wheezing, Hyperhidrosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Emend
    Administration route: Oral
    Indication: Nausea
    Start date: 2011-10-14

Emend
    Administration route: Oral
    Start date: 2010-01-01

Emend
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2011-10-14

Emend
    Administration route: Oral
    Start date: 2010-01-01



Possible Emend side effects in 68 year old male

Reported by a pharmacist from United States on 2011-11-28

Patient: 68 year old male

Reactions: Anxiety, Respiratory Disorder, Dyspnoea, Chest Discomfort, Nausea, Chills, Wheezing, Hyperhidrosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Emend
    Administration route: Oral
    Indication: Nausea
    Start date: 2011-10-14

Emend
    Administration route: Oral
    Start date: 2010-01-01

Emend
    Administration route: Oral
    Start date: 2010-01-01

Emend
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2011-10-14



Possible Emend side effects in 68 year old male

Reported by a pharmacist from United States on 2011-11-28

Patient: 68 year old male

Reactions: Anxiety, Chest Discomfort, Respiratory Disorder, Dyspnoea, Nausea, Wheezing, Chills, Hyperhidrosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Emend
    Administration route: Oral
    Start date: 2010-01-01

Emend
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2011-10-14

Emend
    Administration route: Oral
    Start date: 2010-01-01

Emend
    Administration route: Oral
    Indication: Nausea
    Start date: 2011-10-14



Possible Emend side effects in 68 year old male

Reported by a pharmacist from United States on 2011-11-23

Patient: 68 year old male

Reactions: Anxiety, Respiratory Disorder, Chest Discomfort, Dyspnoea, Nausea, Chills, Wheezing, Hyperhidrosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Emend
    Administration route: Oral
    Indication: Nausea
    Start date: 2011-10-14

Emend
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2011-10-14

Emend
    Administration route: Oral
    Start date: 2010-01-01

Emend
    Administration route: Oral
    Start date: 2010-01-01



Possible Emend side effects in 68 year old male

Reported by a pharmacist from United States on 2011-11-03

Patient: 68 year old male

Reactions: Anxiety, Respiratory Disorder, Chest Discomfort, Dyspnoea, Nausea, Chills, Wheezing, Hyperhidrosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Emend
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2011-10-14

Emend
    Administration route: Oral
    Indication: Nausea
    Start date: 2011-10-14

Emend
    Administration route: Oral
    Start date: 2010-01-01

Emend
    Administration route: Oral
    Start date: 2010-01-01



Possible Emend side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-14

Patient: 60 year old male, weighing 98.0 kg (215.6 pounds)

Reactions: Blood Pressure Increased, Back Pain, Flushing, Dyspnoea, Flank Pain, Erythema

Drug(s) suspected as cause:
Emend

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017